Sofcom Systems (538923)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Profit growth of 233.33% and a low PEG of 0.26 indicate earnings momentum, albeit from a very low base
• High reported ROE of 106.31% suggests the company can generate returns on its small equity base
• Piotroski F-Score of 5/9 implies the financial health is not deeply distressed
• Current price of ₹35.49 is well above the 52-week low of ₹19.17, showing some buyer interest

Concerns

• Sales are declining sharply at -35.79%, and the latest quarter revenue is only ₹1 crore with zero net profit
• Valuation is expensive: P/E of 60.74 and P/B of 16.58 against book value of just ₹2.14 per share
• ROCE is 0.00%, dividend yield is 0.00%, and promoter holding is not disclosed, creating a serious transparency gap
• Market cap of ₹86 crore rests on an extremely small earnings and revenue base, leaving no margin of safety

AI Analysis

Let me start with what a shareholder should ask: what does this business earn, and can it grow? Sofcom Systems has a market cap of ₹86 crore, yet its latest quarter shows sales of just ₹1 crore and net profit of ₹0 crore. Based on the P/E of 60.74, the market is asking me to pay roughly 60 years of current earnings for a company whose sales have fallen 35.79%. Graham taught me that price is what you pay, value is what you get. Here, I see little value. The reported ROE of 106.31% looks spectacular, but it rests on a tiny book value of ₹2.14 per share. Return on capital employed is zero, dividend yield is zero, and promoter holding is not disclosed. I do not invest in what I cannot see. The 52-week range of ₹19.17 to ₹92.00 tells a story of speculation, not steady compounding. A Piotroski score of 5/9 is mediocre. Yes, profit growth of 233.33% and a PEG of 0.26 tempt a growth investor, but when the base is near zero, percentage growth is meaningless. Sofcom may one day become a fine turnaround, but at ₹35.49 I am not being paid to assume that risk. A weak business is only worth buying at a significant discount. There is no margin of safety here. I would watch from the sidelines until sales stabilise, quarterly profitability returns, and management proves its capital allocation.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer